Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zong Sheng Guo

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of Surgical Oncology|May 16, 2012
Mucin as a therapeutic target in pseudomyxoma peritoneiHaroon A Choudry, Mark E O'Malley, Zong Sheng Guo, et al.
Journal for Immunotherapy of Cancer|May 29, 2020
Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancerFan Sun, Zong Sheng Guo, Alyssa D Gregory, et al.
Molecular Cancer|September 12, 2013
Oncolytic viruses as therapeutic cancer vaccinesDavid L Bartlett, Zuqiang Liu, Magesh Sathaiah, et al.
Oncolytic Virotherapy|February 27, 2019
A cautionary note on the selectivity of oncolytic poxvirusesBingtao Tang, Zong Sheng Guo, David L Bartlett, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 22, 2015
Targeting hypoxia-mediated mucin 2 production as a therapeutic strategy for mucinous tumorsAshok K Dilly, Yong J Lee, Herbert J Zeh, et al.
Biomedicines|June 24, 2022
Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer ImmunotherapyWeilin Liu, Hongqi Chen, Zhi Zhu, et al.
Frontiers in Immunology|May 31, 2017
Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future PerspectivesZong Sheng Guo, Zuqiang Liu, Stacy Kowalsky, et al.
Oncotarget|March 10, 2016
Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancerLily Francis, Zong Sheng Guo, Zuqiang Liu, et al.
Frontiers in Immunology|March 8, 2021
<i>In Vivo</i> Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell TherapyEsther Giehl, Hiromichi Kosaka, Zuqiang Liu, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 24, 2021
Intrapleural interleukin-2-expressing oncolytic virotherapy enhances acute antitumor effects and T-cell receptor diversity in malignant pleural diseaseChigozirim N Ekeke, Kira L Russell, Pranav Murthy, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Surgical Oncology|May 16, 2012
Mucin as a therapeutic target in pseudomyxoma peritoneiHaroon A Choudry, Mark E O'Malley, Zong Sheng Guo, et al.
Journal for Immunotherapy of Cancer|May 29, 2020
Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancerFan Sun, Zong Sheng Guo, Alyssa D Gregory, et al.
Molecular Cancer|September 12, 2013
Oncolytic viruses as therapeutic cancer vaccinesDavid L Bartlett, Zuqiang Liu, Magesh Sathaiah, et al.
Oncolytic Virotherapy|February 27, 2019
A cautionary note on the selectivity of oncolytic poxvirusesBingtao Tang, Zong Sheng Guo, David L Bartlett, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 22, 2015
Targeting hypoxia-mediated mucin 2 production as a therapeutic strategy for mucinous tumorsAshok K Dilly, Yong J Lee, Herbert J Zeh, et al.
Biomedicines|June 24, 2022
Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer ImmunotherapyWeilin Liu, Hongqi Chen, Zhi Zhu, et al.
Frontiers in Immunology|May 31, 2017
Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future PerspectivesZong Sheng Guo, Zuqiang Liu, Stacy Kowalsky, et al.
Oncotarget|March 10, 2016
Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancerLily Francis, Zong Sheng Guo, Zuqiang Liu, et al.
Frontiers in Immunology|March 8, 2021
<i>In Vivo</i> Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell TherapyEsther Giehl, Hiromichi Kosaka, Zuqiang Liu, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 24, 2021
Intrapleural interleukin-2-expressing oncolytic virotherapy enhances acute antitumor effects and T-cell receptor diversity in malignant pleural diseaseChigozirim N Ekeke, Kira L Russell, Pranav Murthy, et al.
Pageof 5